Revolutionize oligonucleotide manufacturing for life-changing therapies.
Capitalize on oligo market momentum.
As more drugs achieve FDA approval and demand increases, your industry is positioned for rapid expansion. But without an established industry standard for your production facility, navigating the transition from clinical to commercial scale is daunting.
How can CRB help you?
Leading oligo researchers and manufacturers come to us as a pioneering force guiding this industry in its commercial infancy. With decades of commercial manufacturing experience to draw from, our engineers devise creative, risk-based solutions for large-scale production based on similar technologies and extensive experience working with oligos in clinical development.
We have been actively involved in the development of oligos from the start. We are as invested as you are in designing efficient, effective and compliant oligo facilities to make these life-saving therapies more widely available.
Let’s envision the future of oligo manufacturing together.
Tell us about your project; we’ll make it a reality.
Download Now – Horizons: Life Sciences
Our 2022 edition of the life sciences report, built on the insights of nearly 500 industry leaders, explores the transformative change this field is poised to undergo in the wake of the pandemic and ever-increasing investment in R&D.